Brodsky & Smith, LLC Announces an Investigation into the Fairness of the Sale Price of Imperva, Inc.– IMPV

BALA CYNWYD, October 10, 2018 /Access Wire/ – Law office of Brodsky & Smith, LLC announces that it is investigating potential claims against the Board of Directors Imperva, Inc.(“Imperva” or “the Company”) (Nasdaq – IMPV-News) for possible breaches of fiduciary duty and other violations of federal and state law in connection with the sale of the Company to the Thoma Bravo, LLC. (“Thoma Bravo”).

Under the terms of the transaction, Imperva shareholders will receive only $55.75 in cash for each share of Imperva stock they own. The investigation concerns whether the Board of Imperva breached their fiduciary duties to shareholders and whether Thoma Bravo is underpaying for the Company. The transaction may undervalue the Company and may not be in the Imperva shareholders best interests. For example,  the transaction would result in a substantial loss for long-term holders of Imperva stock, which has traded at $74.63 per share. In addition, an analyst has placed a $65.00 per share price target on Imperva stock.

If you own shares of Imperva stock and wish to discuss the legal ramifications of  the investigation, or have any questions, you may e-mail or call the law office of Brodsky & Smith, LLC who will, without obligation or cost to you, attempt to answer your questions. You may contact Jason L. Brodsky, Esquire or Evan J. Smith, Esquire at Brodsky & Smith, LLC, Two Bala Plaza, Suite 510, Bala Cynwyd, PA  19004, or calling toll free 877-LEGAL-90.

Brodsky & Smith, LLC is a litigation law firm with extensive expertise representing shareholders throughout the nation in securities and class action lawsuits. The attorneys at Brodsky & Smith have been appointed by numerous courts throughout the country to serve as lead counsel in class actions and have successfully recovered millions of dollars for our clients and shareholders. Attorney advertising. Prior results do not guarantee a similar outcome.